{"id":39784,"date":"2020-11-02T04:02:09","date_gmt":"2020-11-02T04:02:09","guid":{"rendered":"https:\/\/blogs.bmj.com\/bmjgh\/?p=39784"},"modified":"2020-11-02T04:04:23","modified_gmt":"2020-11-02T04:04:23","slug":"how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/","title":{"rendered":"How the World Trade Organization could facilitate access to COVID-19 health technologies?"},"content":{"rendered":"

Governments have faced difficult decisions over the past months, but the decision to remove unnecessary barriers to accessing COVID-19 health technologies like vaccines, diagnostics and treatments should be an obvious one. This decision is currently under debate among member states of the World Trade Organization, who are considering a proposal to waive global intellectual property rules for COVID-19 health technologies to combat COVID-19.<\/p>\n

What is the waiver proposal?<\/em><\/strong><\/p>\n

On October 2, 2020 India and South Africa tabled a proposal<\/a> to the World Trade Organization\u2019s Council for Trade-Related Intellectual Property Rights asking member states to waive a range of intellectual property (IP) measures on health technologies related to COVID-19 \u2018until widespread vaccination is in place globally, and the majority of the world\u2019s population has developed immunity\u2019.<\/p>\n

The proposal, if accepted, would allow countries greater flexibility in choosing to deny granting of patents or other IP on COVID-19 diagnostics, vaccines, and other technologies such as personal protective equipment.<\/p>\n

Currently, member states of the World Trade Organization must provide IP protection and enforcement across a range of measures, including at least 20 years patent protection. During this period the patent holder has a monopoly on a product and cheaper generic versions cannot enter the market. Least developed countries (LCDs) have an extension<\/a> on IP for pharmaceuticals until 1 January 2033 or when they \u2018graduate\u2019 out of the LDC category if earlier.<\/p>\n

India and South Africa\u2019s proposal highlights the barrier that IP can serve to technology transfer and manufacturing of COVID-19 health technologies, and provides an explicit avenue for the removal of IP barriers. The proposal has received widespread support from more than 30 low and middle income countries<\/a>, over 400 global health civil society<\/a> organisations, the World Health Organization<\/a> (WHO), UNAIDS<\/a> and UNITAD<\/a>.<\/p>\n

\"World
World Trade Organization : people’s health or profits ? Illustrative Image by Giovanni Maki.<\/figcaption><\/figure>\n

 <\/p>\n

How can the waiver facilitate access to health technologies?<\/em><\/strong><\/p>\n

Medicines and vaccines under IP monopolies are increasingly prohibitively expensive. This was illustrated during the HIV\/AIDS epidemic where the original monopoly price for HIV\/AIDS drugs at $10,000 per patient per year<\/a> was unaffordable not only for low and middle income countries, but for patients in high income countries too.<\/p>\n

Global demands for affordable access to HIV\/AIDS treatments were the catalyst for a 2003 waiver<\/a> at the World Trade Organization which established a mechanism for countries producing generic medicines to supply to other countries who lacked manufacturing capacity to produce the medicine themselves.<\/p>\n

IP barriers to access have been laid bare once again in this pandemic. Countries are experiencing delays to diagnostics and lifesaving technologies, personal protective equipment, promising treatments under patent, and numerous patent filings on vaccine candidates. For example, Medicines Sans Frontiers<\/em><\/a> has documented patent barriers leading to shortages of testing kit reagents, ventilators, and N95 respirators across various countries.<\/p>\n

As countries commit billions of dollars<\/a> of public funding to the development of promising COVID-19 vaccines, global health organisations are supporting measures that remove IP barriers. Winnie Byanyima, Executive Director of UNAIDS argues<\/a> that \u201cwe cannot repeat the painful lessons from the early years of the AIDS response, when people in wealthier countries got back to health, while millions of people in developing countries were left behind.\u201d<\/p>\n

Part of the wider problem for access to COVID-19 vaccines is an emerging inequity in advance purchasing agreements<\/a> with promising candidate owners. Oxfam<\/a> shows that a select number of high income countries, representing 13 per cent of the world\u2019s population, have secured 51% of COVID-19 vaccine candidates through these kind of agreements. A recent Nature article<\/a> reveals that the UK has pre-ordered enough vaccines for 5 doses per person, while allocation to low and middle income countries is less than 0.2 people per capita.<\/p>\n

The WTO proposal is in response to lack of commitment to the WHO\u2019s COVID-19 Technology Access Pool (C-TAP), launched in May to encourage the voluntarily sharing of IP, technologies and data to support global manufacturing and scale up of COVID-19 technologies. So far, no pharmaceutical firm has committed to sharing its IP and technologies in the pool, prompting India<\/a> to push for the waiver at the WTO.<\/p>\n

At the recent 16th<\/sup> October meeting of the WTO TRIPS Council, several high income countries including the United States, United Kingdom, Canada and Australia, did not support the waiver proposal. Informal consultations are now underway in advance of the next TRIPS Council meeting in December.<\/p>\n

There are several arguments in support of the COVID-19 waiver for all countries. Quicker access to a new vaccine or treatment around the world would; facilitate faster global economic recovery through improved trade and ending of lockdowns; benefit health security to mitigate the spread of this highly infectious disease across countries; and, most importantly, save lives and reduce COVID morbidity for everyone regardless of the country they live in. The choice countries and WTO is making is simple –\u00a0 to prioritize people\u2019s health, or profits.<\/p>\n

About the authors<\/strong>:<\/p>\n

Belinda Townsend<\/strong> is a Research Fellow in the School of Regulation and Global Governance at the Australian National University. She works on the political economy of health and health governance.<\/p>\n

Jordan D. Jarvis<\/strong> is a Doctor of Public Health candidate at the London School of Hygiene and Tropical Medicine. Her research interests include health policy and governance, access to medicines, and the political economy of non-communicable disease treatment and prevention.<\/p>\n

Conflict of interest:<\/strong><\/p>\n

We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: Belinda Townsend has represented the Public Health Association of Australia on matters relating to trade and health. Jordan D. Jarvis is funded by the Canadian Institutes for Health Research (CIHR). CIHR had no role in this article.<\/p>\n

Handling Editor: Soumyadeep Bhaumik<\/p>\n","protected":false},"excerpt":{"rendered":"

Governments have faced difficult decisions over the past months, but the decision to remove unnecessary barriers to accessing COVID-19 health technologies like vaccines, diagnostics and treatments should be an obvious one. This decision is currently under debate among member states of the World Trade Organization, who are considering a proposal to waive global intellectual property […]<\/p>\n

Read More…<\/a><\/p>\n","protected":false},"author":350,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[28,16,29,32,35],"tags":[164,314,108,315,313,312],"class_list":["post-39784","post","type-post","status-publish","format-standard","hentry","category-global-health-financing","category-health-financing","category-international-development","category-universal-health-coverage","category-world-health-organisation","tag-covid-19","tag-healthcare-technology","tag-india","tag-intellectual-property","tag-south-africa","tag-world-trade-organisation"],"yoast_head":"\nHow the World Trade Organization could facilitate access to COVID-19 health technologies? - BMJ Global Health blog<\/title>\n<meta name=\"description\" content=\"World Trade Organization, should waive global intellectual property rules for COVID-19 health technologies a sproposed by India & South Africa\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How the World Trade Organization could facilitate access to COVID-19 health technologies? - BMJ Global Health blog\" \/>\n<meta property=\"og:description\" content=\"World Trade Organization, should waive global intellectual property rules for COVID-19 health technologies a sproposed by India & South Africa\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/\" \/>\n<meta property=\"og:site_name\" content=\"BMJ Global Health blog\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-02T04:02:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-02T04:04:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogs.bmj.com\/bmjgh\/files\/2020\/04\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png\" \/>\n<meta name=\"author\" content=\"BMJ GH Blogs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@GlobalHealthBMJ\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ GH Blogs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/\"},\"author\":{\"name\":\"BMJ GH Blogs\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#\\\/schema\\\/person\\\/3254f79953488a538451e03917a70749\"},\"headline\":\"How the World Trade Organization could facilitate access to COVID-19 health technologies?\",\"datePublished\":\"2020-11-02T04:02:09+00:00\",\"dateModified\":\"2020-11-02T04:04:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/\"},\"wordCount\":962,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/files\\\/2020\\\/04\\\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png\",\"keywords\":[\"COVID-19\",\"healthcare technology\",\"India\",\"intellectual property\",\"South Africa\",\"World Trade Organisation\"],\"articleSection\":[\"Global health financing\",\"Health financing\",\"International development\",\"Universal health coverage\",\"World Health Organisation\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/\",\"name\":\"How the World Trade Organization could facilitate access to COVID-19 health technologies? - BMJ Global Health blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/files\\\/2020\\\/04\\\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png\",\"datePublished\":\"2020-11-02T04:02:09+00:00\",\"dateModified\":\"2020-11-02T04:04:23+00:00\",\"description\":\"World Trade Organization, should waive global intellectual property rules for COVID-19 health technologies a sproposed by India & South Africa\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/files\\\/2020\\\/04\\\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/files\\\/2020\\\/04\\\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png\",\"width\":600,\"height\":364,\"caption\":\"World Trade Organization : health or profits ? Illustrative Image by Giovanni Maki.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/2020\\\/11\\\/02\\\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How the World Trade Organization could facilitate access to COVID-19 health technologies?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/\",\"name\":\"BMJ Global Health blog\",\"description\":\"Comment, discussion and debate on all aspects of global health across BMJ\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#organization\",\"name\":\"BMJ Global Health blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/files\\\/2017\\\/11\\\/blog-logo-gh.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/files\\\/2017\\\/11\\\/blog-logo-gh.png\",\"width\":275,\"height\":34,\"caption\":\"BMJ Global Health blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/#\\\/schema\\\/person\\\/3254f79953488a538451e03917a70749\",\"name\":\"BMJ GH Blogs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b01b54a4bc1976f57bc48ef664464267cc8630a33baeabf02fdbca0efe720555?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b01b54a4bc1976f57bc48ef664464267cc8630a33baeabf02fdbca0efe720555?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b01b54a4bc1976f57bc48ef664464267cc8630a33baeabf02fdbca0efe720555?s=96&d=mm&r=g\",\"caption\":\"BMJ GH Blogs\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/GlobalHealthBMJ\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjgh\\\/author\\\/soumyadeepbhaumik\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How the World Trade Organization could facilitate access to COVID-19 health technologies? - BMJ Global Health blog","description":"World Trade Organization, should waive global intellectual property rules for COVID-19 health technologies a sproposed by India & South Africa","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/","og_locale":"en_US","og_type":"article","og_title":"How the World Trade Organization could facilitate access to COVID-19 health technologies? - BMJ Global Health blog","og_description":"World Trade Organization, should waive global intellectual property rules for COVID-19 health technologies a sproposed by India & South Africa","og_url":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/","og_site_name":"BMJ Global Health blog","article_published_time":"2020-11-02T04:02:09+00:00","article_modified_time":"2020-11-02T04:04:23+00:00","og_image":[{"url":"https:\/\/blogs.bmj.com\/bmjgh\/files\/2020\/04\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png","type":"","width":"","height":""}],"author":"BMJ GH Blogs","twitter_card":"summary_large_image","twitter_creator":"@GlobalHealthBMJ","twitter_misc":{"Written by":"BMJ GH Blogs","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/"},"author":{"name":"BMJ GH Blogs","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#\/schema\/person\/3254f79953488a538451e03917a70749"},"headline":"How the World Trade Organization could facilitate access to COVID-19 health technologies?","datePublished":"2020-11-02T04:02:09+00:00","dateModified":"2020-11-02T04:04:23+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/"},"wordCount":962,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/#organization"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmjgh\/files\/2020\/04\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png","keywords":["COVID-19","healthcare technology","India","intellectual property","South Africa","World Trade Organisation"],"articleSection":["Global health financing","Health financing","International development","Universal health coverage","World Health Organisation"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/","url":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/","name":"How the World Trade Organization could facilitate access to COVID-19 health technologies? - BMJ Global Health blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/#primaryimage"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/#primaryimage"},"thumbnailUrl":"https:\/\/blogs.bmj.com\/bmjgh\/files\/2020\/04\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png","datePublished":"2020-11-02T04:02:09+00:00","dateModified":"2020-11-02T04:04:23+00:00","description":"World Trade Organization, should waive global intellectual property rules for COVID-19 health technologies a sproposed by India & South Africa","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/#primaryimage","url":"https:\/\/blogs.bmj.com\/bmjgh\/files\/2020\/04\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png","contentUrl":"https:\/\/blogs.bmj.com\/bmjgh\/files\/2020\/04\/1200px-Examination_of_worlds_health_-_journal.pmed_.0010003.g001-e1587595607985.png","width":600,"height":364,"caption":"World Trade Organization : health or profits ? Illustrative Image by Giovanni Maki."},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmjgh\/2020\/11\/02\/how-the-world-trade-organization-could-facilitate-access-to-covid-19-health-technologies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmjgh\/"},{"@type":"ListItem","position":2,"name":"How the World Trade Organization could facilitate access to COVID-19 health technologies?"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#website","url":"https:\/\/blogs.bmj.com\/bmjgh\/","name":"BMJ Global Health blog","description":"Comment, discussion and debate on all aspects of global health across BMJ","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmjgh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#organization","name":"BMJ Global Health blog","url":"https:\/\/blogs.bmj.com\/bmjgh\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmjgh\/files\/2017\/11\/blog-logo-gh.png","contentUrl":"https:\/\/blogs.bmj.com\/bmjgh\/files\/2017\/11\/blog-logo-gh.png","width":275,"height":34,"caption":"BMJ Global Health blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjgh\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmjgh\/#\/schema\/person\/3254f79953488a538451e03917a70749","name":"BMJ GH Blogs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b01b54a4bc1976f57bc48ef664464267cc8630a33baeabf02fdbca0efe720555?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b01b54a4bc1976f57bc48ef664464267cc8630a33baeabf02fdbca0efe720555?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b01b54a4bc1976f57bc48ef664464267cc8630a33baeabf02fdbca0efe720555?s=96&d=mm&r=g","caption":"BMJ GH Blogs"},"sameAs":["https:\/\/x.com\/GlobalHealthBMJ"],"url":"https:\/\/blogs.bmj.com\/bmjgh\/author\/soumyadeepbhaumik\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/posts\/39784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/users\/350"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/comments?post=39784"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/posts\/39784\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/media?parent=39784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/categories?post=39784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjgh\/wp-json\/wp\/v2\/tags?post=39784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}